Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q54474131)
Watch
English
Biocon's first-in-class anti-CD6 mAb reaches the market.
scientific article
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24316625
retrieved
30 May 2018
reference URL
http://europepmc.org/abstract/MED/24316625
title
Biocon's first-in-class anti-CD6 mAb reaches the market.
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24316625
retrieved
30 May 2018
reference URL
http://europepmc.org/abstract/MED/24316625
author name string
Killugudi Jayaraman
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24316625
retrieved
30 May 2018
reference URL
http://europepmc.org/abstract/MED/24316625
publication date
1 December 2013
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24316625
retrieved
30 May 2018
reference URL
http://europepmc.org/abstract/MED/24316625
published in
Nature Biotechnology
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24316625
retrieved
30 May 2018
reference URL
http://europepmc.org/abstract/MED/24316625
volume
31
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24316625
retrieved
30 May 2018
reference URL
http://europepmc.org/abstract/MED/24316625
issue
12
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24316625
retrieved
30 May 2018
reference URL
http://europepmc.org/abstract/MED/24316625
page(s)
1062-1063
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24316625
retrieved
30 May 2018
reference URL
http://europepmc.org/abstract/MED/24316625
cites work
A clinical exploratory study with itolizumab, an anti-CD6 monoclonal antibody, in patients with rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNBT1213-1062B
retrieved
21 January 2018
Ustekinumab poised to enter the psoriasis market
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/24316625
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1038/NBT1213-1062B
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24316625
retrieved
30 May 2018
reference URL
http://europepmc.org/abstract/MED/24316625
PubMed publication ID
24316625
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24316625
retrieved
30 May 2018
reference URL
http://europepmc.org/abstract/MED/24316625
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
